The market of 2025 will be remembered for its extremes. While investors poured billions into technology sector giants and ...

Two years into the pandemic, COVID-19’s potential to fuel domestic drug manufacturing hasn’t faded. Take Pfizer’s new $120 million investment, for example. The company on Monday said it’s plugging the ...

About two years ago, Pfizer acquired Wyeth to create what it says is the world’s largest biopharmaceutical company offering products in a variety of therapeutic areas. Wyeth brought to the merger an ...

Pfizer is sticking with the U.S. and Europe in producing its COVID-19 vaccine Comirnaty—at least until the "pandemic supply phase" is over, the company said Thursday. Contrary to media reports, the ...

Drug giant Pfizer is informing hospitals that dozens of its products could face “continued or new supply disruptions in the near-term” after an EF-3 tornado last week severely damaged its plant in ...

Pfizer’s newest vaccine manufacturing site has history of mold, recall troubles The McPherson, Kan., facility slated to be used as a fill-and-finish site for Pfizer COVID-19 vaccines has a history of ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a multi-year collaboration with GSK on the development of a next-generation equipment design, building upon Pfizer’s existing portable ...

Andover, Mass.-based biopharmaceutical company Pfizer began constructing its new $200 million biologics manufacturing facility Thursday. The five-story, 175,000-square-foot addition to Pfizer's ...

When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn’t just developing a Covid-19 vaccine — they also had to make it, and by the hundreds of millions. This was no small feat ...

When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn’t just developing a Covid-19 vaccine — they also had to make it, and by the hundreds of millions. This was no small feat ...